期刊文献+

经抽吸导管冠状动脉内注射替罗非班对急诊介入治疗无复流的影响 被引量:7

Effect of trofiban injected into coronary artery via a suction catheteron on no reflow during PCI
下载PDF
导出
摘要 目的探讨经抽吸导管冠状动脉注射血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂替罗非班对急性ST段抬高型心肌梗死患者急诊PCI术中无复流的影响。方法 60例急诊PCI术并全部使用抽吸导管的急性ST段抬高型心肌梗死的患者随机分为2组,常规组30例,在急诊冠状动脉造影抽吸治疗后,经指引导管应用替罗非班,常规剂量外周静脉持续泵入;实验组30例,常规组基础上,经抽吸导管冠状动脉内注射替罗非班,常规剂量外周静脉持续泵入。比较2组围术期出血、梗死相关血管恢复前向血流情况。结果实验组首次用药的罪犯血管TIMI 2~3级比例显著高于常规组(86.67%vs 63.33%,χ2=4.356,P=0.037);末次用药的罪犯血管TIMI 2~3级比例显著高于常规组(93.33%vs 70.00%,χ2=5.455,P=0.020);实验组TIMI 3级比例显著高于常规组(66.67%vs 30.00%,P〈0.05),2组表面出血和内脏出血比较,差异无统计学意义(3.33%vs 3.33%,3.33%vs 6.67%,χ2=0.351,P=0.554)。2组围术期和术后近期均无心脏不良事件发生。结论急性ST段抬高型心肌梗死患者在急诊PCI术时,经过抽吸导管注射替罗非班,能有效地改善梗死相关血管前向血流。 Objective To study the effect of trofiban(aplatelet glycoprotein Ⅱb/Ⅲa receptor)injected into coronary artery via a suction catheter on no reflow in patients with ST-segment elevation acute myocardial infarction during PCI.Methods Sixty patients with ST-segment elevation acute myocardial infarction who underwent emergency PCI via a suction catheter were randomly divided into control group(n=30)and experimental group(n=30).The patients in control group were treated with catheter-guided trofiban injection after coronary angiography and those in experimental group were treated with trofiban injection via a suction catheter.The bleeding and infarction-related blood flow were compared between the 2groups during perioperative period.Results The culprit artery TIMI 2-3ratio and TIMI 3ratio were significantly higher in experimental group than in control group(86.67% vs 63.33%,χ2=4.356,P〈0.05;66.67% vs30.00%,P〈0.05).No significant difference was found in bleeding between the two groups(3.33%vs 6.67%,χ2=0.351,P=0.554).Conclusion Tirofiban injection via a suction catheter can effectively improve infarction-related blood flow in patients with ST-segment elevation acute myocardial infarction during emergency PCI.
出处 《中华老年心脑血管病杂志》 CAS 2015年第10期1041-1043,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 抽吸 血小板糖蛋白GPⅡb-Ⅲa复合物 冠状血管造影术 心肌梗死 无复流现象 suction platelet glycoprotein GPⅡb-Ⅲa complex coronary angiography myocardial infarction no-reflow phenomenon
  • 相关文献

参考文献3

二级参考文献27

  • 1杨新春,张大鹏,王乐丰,徐立,葛永贵,王红石,李惟铭,倪祝华,夏昆,连勇,薛永利,马利祥.冠状动脉内应用国产替罗非班对急性ST段抬高心肌梗死急诊介入治疗后心肌灌注和临床预后的影响[J].中华心血管病杂志,2007,35(6):517-522. 被引量:73
  • 2Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 3Ito H, Okamura A, Iwakura K, et al.Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction[J].Circulation, 1996, 93: 1993-1999.
  • 4Tanaka A, Kawarabayashi T, Nishibori Y, et al.No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction[J].Circulation, 2002, 105: 2148- 2152.
  • 5Yip HK, Chen MC, Chang HW, et al.Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon[J].Chest, 2002, 122:1322-1332.
  • 6Hara M, Saikawa T, Tsunematsu Y, et al.Predicting no-reflow based on angiographic features of lesions in patients with acute myocardial infarction[J].J Atheroscler Thromb, 2005, 12:315-321.
  • 7Chesebro JH, Knatterud G, Roberts R, et al.Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase.Clinical findings through hospital discharge[J].Circulation, 1987, 76:142-154.
  • 8Gibson CM, Cannon CP, Murphy SA, et al.Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs[J].Circulation, 2000, 101:125-130.
  • 9O′Gara PT, Kushner FG, Ascheim DD,et al.2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol, 2013,61:e78-e140.
  • 10Hillegass WB, Dean NA, Liao L, et al.Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience[J].J Am Coll Cardiol, 2001, 37: 1335-1343.

共引文献2031

同被引文献69

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部